Simavita Limited

ASX Appendix 4C for the Quarter Ended June 30, 2015

SYDNEY, AUSTRALIA--(Marketwired - July 30, 2015) - Simavita Limited (ASX:SVA)(TSX VENTURE:SV) ("Simavita" or the "Company"), a global leader in the digital healthcare sector, is pleased to release its ASX Appendix 4C for the quarter ended June 30, 2015.

Cash receipts from customers for the quarter were $141,246, taking the total receipts for the full 2015 financial year to $701,743. This annual figure represents an increase of 88% over the total cash receipts from customers for the 2014 financial year of $373,321.

During the June quarter, the Company successfully concluded a placement of 18,517,490 common shares and CDIs at an issue price of $0.45 per security. This placement raised a total of $8,332,871, prior to the payment of associated costs of $298,628. As a result of the above capital raising, the total cash and cash equivalents held by Simavita at the end of June 2015 was $9,027,722, which represented an increase of 32% over the cash balance as at the end of the previous financial year.

Quarterly operational highlights

A number of operational highlights were recorded during the June quarter, including:

• The successful closing of the Company's $8.3 million placement, with strong support from high quality institutional and sophisticated investors in Hong Kong, the USA and Australia, including WF Asian Reconnaissance Fund Limited.
• Signing non-exclusive sales and marketing partnership agreements in Australia with major continence product distributors, Bunzl and (immediately post the quarter) HARTMANN.
• The commencement of development work under which Simavita will integrate its Smart Incontinence Management™ (SIM™) platform with the Electronic Health Record system distributed by MatrixCare, one of the largest providers of such systems in the US.
• Commencement of a major research project in Denmark, alongside local distributor Abena, with nine aged care facilities.
• Advancing negotiations with parties to extend the distribution of SIM™ into other European countries.

Simavita's CEO, Mrs. Philippa Lewis commented, "The June quarter was important for Simavita as we used the period to further build on the foundations that will support our activities in the key markets of Australia, North America and Europe.